Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 12,916 |
|
|||||
| News | - | ||||||
| Day High | 1.10 | Low High |
|||||
| Day Low | 1.04 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zentek Ltd | ZTEK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0673 | -6.07% | 1.0423 | 11:42:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.10 | 1.04 | 1.10 | 1.1096 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 79 | 12,916 | $ 1.06 | $ 13,702 | - | 0.974999 - 1.7494 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:39:04 | 920 | $ 1.0423 | USD |
Zentek Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 143.16M | 100.82M | - | 73k | -14.41M | -0.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Zentek News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZTEK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.15 | 1.20 | 1.04 | 1.14 | 15,348 | -0.1077 | -9.37% |
| 1 Month | 1.30 | 1.30 | 1.03 | 1.18 | 22,430 | -0.2577 | -19.82% |
| 3 Months | 1.17 | 1.48 | 1.03 | 1.25 | 20,529 | -0.1277 | -10.91% |
| 6 Months | 1.17 | 1.59 | 0.974999 | 1.22 | 22,074 | -0.1277 | -10.91% |
| 1 Year | 1.64 | 1.7494 | 0.974999 | 1.33 | 21,110 | -0.5977 | -36.45% |
| 3 Years | 3.00 | 3.78 | 0.974999 | 2.55 | 56,121 | -1.96 | -65.26% |
| 5 Years | 3.00 | 3.78 | 0.974999 | 2.55 | 56,121 | -1.96 | -65.26% |
Zentek Description
| Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology. |
